METHODS TO IDENTIFY AND SELECTIVELY EXPAND TUMOR ANTIGEN-SPECIFIC T CELLS Read more about METHODS TO IDENTIFY AND SELECTIVELY EXPAND TUMOR ANTIGEN-SPECIFIC T CELLS Patent Cooperation TreatyPCT/US2025/022247Filed on 2025-03-31
3-O-SULFO-GALACTOSYLCERAMIDE ANALOGS AS ACTIVATORS OF TYPE II NKT CELLS AND USES THEREOF Read more about 3-O-SULFO-GALACTOSYLCERAMIDE ANALOGS AS ACTIVATORS OF TYPE II NKT CELLS AND USES THEREOF US Application 19/069,431Filed on 2025-03-04
ANTIANGIOGENIC THERAPY IN COMBINATION WITH IMMUNOTOXIN AND ANTI-CD40 TO IMPROVE SURVIVAL IN BRAIN CANCER AND OTHER NEOPLASMS Read more about ANTIANGIOGENIC THERAPY IN COMBINATION WITH IMMUNOTOXIN AND ANTI-CD40 TO IMPROVE SURVIVAL IN BRAIN CANCER AND OTHER NEOPLASMS US Application 63/706,247Filed on 2024-10-11
T CELL RECEPTORS RECOGNIZING MUTATED P53 Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53 South Korea10-2025-7002917Filed on 2025-01-24
CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF Read more about CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF Patent Cooperation TreatyPCT/US2024/062127Filed on 2024-12-27
CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF Read more about CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF Patent Cooperation TreatyPCT/US2024/062156Filed on 2024-12-27
CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF Read more about CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF US Application 63/616,183Filed on 2023-12-29
CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF Read more about CONSTRUCTS TARGETING MSLN PEPTIDE/MHC COMPLEXES AND USES THEREOF US Application 63/616,190Filed on 2023-12-29
AUGMENTING MITOCHONDRIA IN IMMUNE CELLS FOR IMPROVED CANCER IMMUNOTHERAPY Read more about AUGMENTING MITOCHONDRIA IN IMMUNE CELLS FOR IMPROVED CANCER IMMUNOTHERAPY European Patent23738432.6Filed on 2025-01-03
AUGMENTING MITOCHONDRIA IN IMMUNE CELLS FOR IMPROVED CANCER IMMUNOTHERAPY Read more about AUGMENTING MITOCHONDRIA IN IMMUNE CELLS FOR IMPROVED CANCER IMMUNOTHERAPY US Application 18/878,307Filed on 2024-12-23